Toxin-Mediated Suppression of Human PBMC Responses During Bacteremia

$325,600U19FY2015AINIH

Oklahoma Medical Research Foundation, Oklahoma City OK

Investigators

Linked publications & trials

Paper 39605478 Paper 39402881 Paper 39343872 Paper 39006170 Paper 38787940 Paper 38722793 Paper 38690733 Paper 38517345 Paper 38405760 Paper 38313302 Paper 38196658 Paper 38195739 Paper 38188188 Paper 38172101 Paper 37581707 Paper 37398192 Paper 37327781 Paper 37066181 Paper 36989362 Paper 36695755 Paper 36677464 Paper 36608260 Paper 36603205 Paper 36201825 Paper 35952496 Paper 35934336 Paper 35377172 Paper 35336127 Paper 35306427 Paper 35202120 Paper 34710063 Paper 34708219 Paper 34507997 Paper 34428280 Paper 34376480 Paper 34199431 Paper 33923232 Paper 33725447 Paper 33646748 Paper 33598692 Paper 33384131 Paper 33174372 Paper 32951280 Paper 32668703 Paper 32294093 Paper 31549765 Paper 31416821 Paper 31022687 Paper 30866434 Paper 30808684 Paper 30806245 Paper 30532653 Paper 30446701 Paper 29980608 Paper 29921614 Paper 29773851 Paper 29704667 Paper 29615400 Paper 29531132 Paper 29474374 Paper 29324866 Paper 29296900 Paper 29059238 Paper 29021229 Paper 28877928 Paper 28865477 Paper 28720697 Paper 28504191 Paper 28465156 Paper 28408624 Paper 28179428 Paper 28031342 Paper 27929378 Paper 27740627 Paper 27604339 Paper 27513522 Paper 27374331 Paper 27320392 Paper 27280620 Paper 27271962 Paper 27113164 Paper 26956785 Paper 26824387 Paper 26713507 Paper 26685208 Paper 26502913 Paper 26120785 Paper 26027496 Paper 25880109 Paper 25260755 Paper 25140930 Paper 25123559 Paper 24891301 Paper 24759136 Paper 24598797 Paper 24000795 Paper 23966633 Paper 23899564 Paper 23876807 Paper 23800654

Abstract

Bacteremia can lead to septic shock and death in infected individuals, yet many aspects of bacteremia remain poorly understood in humans. In particular the host responses to bacterial components and the suppression of these responses by virulence factors in humans mononuclear cells has not been fully investigated and this has limited the development pf new therapeutics. Using Bacillus anthracis as a model system we are investigating inflammatory stimuli (peptidoglycan) and modulation of responses to this stimuli by anthrax toxin. In particular we are characterizing the induction of antimicrobials by PGN and studying how anthrax lethal toxin, but not edema toxin, suppresses this response. The first aim of this project is to characterize the BaPGN-induced antimicrobial response and its modulation by anthrax toxin in human PBMCs. The second aim is to characterize the differential mechanisms by which LT and ET modulate inflammatory and antimicrobial responses. The final aim is to examine the interplay between BaPGNinduced proinflammatory/antimicrobial factors and their suppression by anthrax toxin in an in vivo model. Completing these aims will address our overall goal of defining the molecular and cellular events occurring between a gram positive pathogen that causes bacteremia and the host responses to that pathogen.

View original record on NIH RePORTER →